Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
Marketing
Eli Lilly forces compounding rival to shed weight loss claims
Eli Lilly has successfully challenged Good Life Meds’ claims about the health benefits and personalization of a compounded tirzepatide product.
Nick Paul Taylor
Nov 6, 2026 4:25am
Lilly lifts guidance on back of another lucrative GLP-1 quarter
Oct 29, 2026 3:31pm
Novo, Lilly unleash dueling GLP-1 datasets at EASD in Milan
Sep 29, 2026 11:20am
Rybelsus brand retired in US as ‘Ozempic pill’ takes the stage
May 1, 2026 8:00am
Lilly warns of 'impurity' in some compounded tirzepatide drugs
Mar 12, 2026 10:00am
FDA unleashes warning letters to firms selling compounded GLP-1s
Mar 4, 2026 8:30am